ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1352	National Cancer Institute	Html	en	Bladder Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of bladder cancer.	bladder infections 0.409188 cancer spreads 0.362526 body 0.421643 type 0.363946 transitional cell carcinoma 0.368057 Partial cystectomy 0.367914 following PDQ summaries 0.361033 PDQ cancer information 0.437047 cancer increases 0.35829 clinical trial search 0.428286 bladder cancer 0.996648 clinical trials 0.716737 stage IV bladder 0.400568 cancer information summary 0.412718 clinical trial 0.562865 Institute about bladder 0.388854 breast cancer prevention 0.364729 superficial bladder cancer 0.471082 patients 0.385176 treatment clinical trial 0.370642 PDQ Adult Treatment 0.359776 NCI PDQ cancer 0.382156 lymph nodes 0.358627 radiation therapy 0.477016 Treatment Editorial Board 0.366853	metastatic bladder cancer 0.451959 General information 0.370997 general cancer information 0.374576 treatment 0.542299 cancer prevention 0.364857 new cancer treatments 0.373348 Recurrent bladder cancer 0.48553 NCI-supported cancer 0.389073 Cancer Information Service 0.375145 urinary diversion 0.368656 invasive bladder cancer 0.467339 treatment clinical trials 0.395244 National Cancer Institute 0.448421 radical cystectomy 0.396674 new treatment 0.433088 External radiation therapy 0.441508 Bladder Cancer Treatment 0.456321 Cancer Care page 0.36454 Blood. The cancer 0.364373 bladder cancer cells 0.466875 cancer research process 0.367381 cancer clinical trials 0.446025 cancer information summaries 0.373713 comprehensive cancer information 0.373405	CLICK HERE
1478	National Cancer Institute	Html	en	Skin Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of skin cancer.	treatment 0.409923 metastatic basal cell 0.400394 subsequent basal cell 0.391984 Skin Cancer Prevention 0.365074 Arch Dermatol 0.471327 photodynamic therapy 0.399886 sun-exposed skin 0.375699 skin cancers 0.433811 primary skin cancers 0.370681 uncomplicated basal cell 0.398522 basal-cell carcinoma 0.373761 PUBMED Abstract 0.376972 Mohs micrographic surgery 0.406259 Invest Dermatol 0.363857 prior skin cancer 0.363746 multiple basal cell 0.397256 nonmelanoma skin cancers 0.400983 recurrence rates 0.396208 Dermatol Surg Oncol 0.421496 periocular basal cell 0.39808 BCC 0.370104 Abstract 0.389392 main skin cancer 0.382703 basal cell nevus 0.404293	squamous cell carcinomas 0.385705 eyelid addresses carcinomas 0.365517 non-eyelid skin cancers 0.367643 surgical excision 0.369879 Br J Dermatol 0.407426 cosmetic results 0.379562 superficial basal cell 0.487048 skin cancer awareness 0.383438 basal cell carcinomas 0.527823 nodular skin BCCs 0.369486 nodular basal cell 0.432753 nonmelanoma skin cancers. 0.373768 nevoid Basal cell 0.396437 primary superficial basal 0.391239 radiation therapy 0.475907 nonmelanoma skin cancer 0.483068 basal cell carcinoma 0.980145 regional lymph nodes 0.369237 radiation therapy treatment 0.376744 longstanding skin ulcers 0.361677 et al. 0.442813 Acad Dermatol 0.422124 squamous cell carcinoma 0.41423	CLICK HERE
1688	National Cancer Institute	Html	en	Cannabis and Cannabinoids (PDQ®)–Patient Version	Expert-reviewed information summary about the use of Cannabis and cannabinoids in the treatment of cancer-related side effects, such as nausea and vomiting.	cancer treatment 0.54874 PDQ Cannabis 0.53541 PDQ cancer information 0.561631 Cancer Complementary 0.483651 cancer therapy 0.493942 clinical trials 0.738523 cannabinoid receptors 0.573547 advanced cancer patients 0.489779 U.S. Food 0.49892 cancer information summary 0.529639 National Institutes 0.485607 alternative cancer therapies 0.482187 clinical trial 0.556349 cancer therapies 0.496308 patients 0.580973 cancer patients 0.559766 Cannabis users 0.54158 Investigational New Drug 0.490753 NCI PDQ cancer 0.493719 cancer information database 0.48226 effects 0.498728 cannabinoids 0.769857 main active cannabinoid 0.509915 treatment 0.563891	breast cancer cells 0.497802 Cannabis plant extract 0.540785 United States 0.581783 Cannabis plant 0.559258 Complementary Therapies Editorial 0.487662 Drug Administration 0.596753 Cancer Information Specialist 0.479354 cancer cells 0.516435 Cancer Information Service 0.529301 Cannabis extract 0.551963 National Cancer Institute 0.60295 studies 0.507275 alternative medicine 0.50524 pain relief 0.516491 advanced cancer 0.497262 approved research settings 0.478938 cannabis 0.903862 chemotherapy-related nausea 0.514076 cancer cell death 0.500487 medicinal Cannabis 0.540165 cancer clinical trials 0.488981 alternative therapies 0.483937 cancer information summaries 0.482387 cancer 0.807964	CLICK HERE
1690	National Cancer Institute	Html	en	Pheochromocytoma and Paraganglioma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of pheochromocytoma and paraganglioma.	cancer treatment 0.520384 malignant tumor cells 0.51392 inherited pheochromocytoma 0.499674 metastatic pheochromocytoma 0.559666 catecholamine levels 0.546812 recurrent pheochromocytoma 0.523941 body 0.55921 PDQ cancer information 0.583541 clinical trial search 0.545652 clinical trials 0.955841 adrenal gland 0.817016 cancer information summary 0.547255 clinical trial 0.684878 blood pressure 0.689096 entire adrenal gland 0.501423 detailed pictures 0.500985 patients 0.570303 pheochromocytoma 0.843137 blood vessels 0.513601 PDQ Pheochromocytoma 0.514265 NCI PDQ cancer 0.498564 lymph nodes 0.51055 radiation therapy 0.504762 tyrosine kinase inhibitor 0.539116	benign pheochromocytoma 0.496121 treatment 0.708415 general information 0.506946 magnetic resonance imaging 0.497402 cancer cells 0.57041 adrenal cortex 0.501382 adrenal medulla 0.501576 multiple endocrine neoplasia 0.503339 treatment clinical trials 0.532049 National Cancer Institute 0.548616 tumor cells 0.524483 new treatment 0.564593 heart rate 0.509798 pheochromocytoma spreads 0.501294 pheochromocytoma cells 0.532172 Pheochromocytoma forms 0.519073 adrenal glands 0.85433 nuclear magnetic resonance 0.499251 paraganglioma 0.578972 tumors 0.523973 cancer clinical trials 0.561663 high blood pressure 0.675166 tumor 0.650897 cancer 0.88724	CLICK HERE
1715	National Cancer Institute	Html	en	Tests to Detect Colorectal Cancer and Polyps	A fact sheet that discusses the advantages and disadvantages of several colorectal cancer screening tests.	standard colonoscopy 0.642704 average risk 0.571434 sigmoidoscopy screening 0.568313 entire colon 0.614214 colorectal polyps 0.605561 abnormal growths 0.57234 colon problems 0.570159 Occult Blood Test 0.556564 early-stage colorectal cancer 0.600935 occult blood tests 0.564372 thorough cleansing 0.581775 asymptomatic colorectal cancer 0.60263 flexible lighted tube 0.561607 colorectal cancer screening 0.734621 flexible sigmoidoscopy screening 0.562785 small polyps 0.567222 digital rectal examination 0.560544 polyps 0.617192 colorectal cancer 0.956004 test 0.736074 new colorectal cancer 0.625336 guaiac FOBT 0.612613 single-specimen guaiac fobt 0.570386 inflammatory bowel disease 0.568257 ) colonoscopy. 0.566733	colon cancer incidence 0.618181 acceptable screening tests 0.563922 fecal occult blood 0.636365 colorectal cancers 0.601521 rectum 0.592026 colon tissue 0.560628 lower colon 0.576523 colon cancer mortality 0.592993 United States 0.573668 Additional procedures 0.566333 colonoscopy screening methods 0.603294 False-positive test results 0.579985 stool sample 0.563739 colorectal cancer incidence 0.613064 colon cancer 0.621651 fecal immunochemical test 0.563508 stool dna test 0.61197 people 0.593294 virtual colonoscopy 0.697133 cancer screening tests 0.581698 family history 0.558032 sigmoid colon 0.589237 colon 0.791161 et al 0.626521	CLICK HERE
1894	National Cancer Institute	Html	es	Tratamiento del cáncer de pulmón de células no pequeñas (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de pulmón de células no pequeñas.	radiocirugía estereotáctica 0.521736 cuáles ganglios 0.544229 estadio iv 0.535294 pequeño corte 0.516426 sustancia llamada fcev 0.511226 faja ajustadora 0.518847 pequeña cantidad 0.570347 Silbido respiratorio 0.522024 cáncer.ampliar broncoscopia 0.521373 gen alk 0.51503 cáncer.ampliar mediastinoscopía 0.517089 células normales.ampliar exploración 0.600106 cuerpo.ampliar radiografía 0.522592 estadios ia 0.514018 rayos x 0.552576 estadio ib 0.557189 estadio ia 0.556394 enlace drugs approved 0.531609 ondas sonoras 0.51647 Non-Small Cell Lung 0.531866 células t 0.528626 vías respiratorias 0.808836	carcinoma epidermoide 0.525518 numerosos ensayos 0.516625 pecho.ampliar biopsia 0.526618 estadios iia 0.515213 estadio iiia 0.625519 determinadas células 0.530359 antecedentes familiares 0.518918 alta potencia 0.516655 estadio iia 0.557019 tirosina cinasa 0.692486 Cell Lung Cancer 0.531364 siguientes sitios 0.51534 siguientes situaciones 0.666362 ecografía ayuda 0.515534 principal factor 0.576142 áreas.ampliar biopsia 0.52208 siguientes formas 0.529859 bronquiolos.ampliar anatomía 0.52368 siguientes sumarios 0.532291 siguientes pruebas 0.527678 vasos sanguíneos 0.979174	CLICK HERE
1951	National Cancer Institute	Html	es	Tratamiento de los síndromes mielodisplásicos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los síndromes mielodisplásicos.	siguientes procedimientos 0.408317 displasia multilinaje 0.404818 células madre 0.698581 leucemia aguda 0.40611 síndromes mielodisplásicos 0.99284 hueso compacto 0.416921 neoplasias mieloides 0.402645 plaquetas maduras 0.410918 célula madre mieloide 0.437557 National Cancer Institute 0.402744 siguientes riesgos 0.401921 vitamina b12 0.403995	Instituto Nacional 0.404912 PDQ Tratamiento 0.439829 célula madre linfoide 0.43173 vidrio piezas 0.403146 neoplasias mielodisplásicas 0.404775 displasia unilinaje 0.404747 Physician Data Query 0.410747 cáncer.ampliar trasplante 0.403337 leucemia mieloide aguda 0.59748 célula madre 0.50311 células sanguíneas maduras 0.465531 siguientes pruebas 0.40454	CLICK HERE
2025	National Cancer Institute	Html	es	Exámenes de detección del cáncer colorrectal (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre las pruebas que se usan para detectar el cáncer colorrectal.	PDQ Exámenes 0.849253 Physician Data Query 0.949845 sigmoidoscopia causa 0.801378 tubo recolector 0.784476 Estados Unidos 0.979222 riesgos.Los exámenes 0.85829 cuerpo).ampliar anatomía 0.797555 prevención revisa 0.744583 radiografías llamada 0.774966	PDQ Prevención 0.956837 pequeño aumento 0.790999 siguientes exámenes 0.980519 información ayuda 0.751125 National Cancer Institute 0.760892 siguientes riesgos 0.742979 siguientes sumarios 0.885224 Instituto Nacional 0.814155	CLICK HERE
16567	National Cancer Institute	Html	en	Pembrolizumab Improves Survival for Some Patients with Advanced Non-Small Cell Lung Cancer	A summary of clinical trial results showing that pembrolizumab improved progression-free and overall survival for patients with advanced non-small cell lung cancer.	platinum-based chemotherapy 0.628936 PD-L1 positive tumors 0.620887 advanced non-small cell 0.629259 PD-L1 expression 0.628117 1-year overall survival 0.61848 higher progression-free survival 0.617259 chemotherapy 0.698592 time patients 0.588415 chemotherapy group 0.668963 immune-mediated adverse events 0.635601 Dana-Farber Cancer Institute 0.607312 lung cancer 0.570765 biomarker. Earlier trials 0.611797 PD-L1 IHC 22C3 0.643265 immune response 0.572023 PD-L1 protein present 0.63991 overall survival 0.629887 immune-mediated deaths 0.578857 National Cancer Institute 0.604313 tumor cells 0.913581 randomized phase 0.574689 median progression-free survival 0.633329 PD-L1-expressing tumor cells 0.661448 immune therapy 0.577956	immune-mediated events 0.578589 progression-free survival 0.757999 pembrolizumab group 0.672943 platinum-based doublet chemotherapy 0.672126 standard chemotherapy 0.609699 phase III CheckMate 0.569846 patients 0.63251 trial results 0.620704 previously treated patients 0.61738 immune cells 0.61252 adverse events 0.670445 Dr. Malik 0.709776 earlier phase trial 0.627214 metastatic NSCLC 0.599852 Bruce E. Johnson 0.59961 survival advantage 0.568599 untreated advanced NSCLC 0.642891 New England Journal 0.615224 severe skin reactions 0.605442 checkpoint inhibitor pembrolizumab 0.658193 phase III trial 0.569107 Pembrolizumab blocks PD-1 0.629649 Shakun Malik 0.582607	CLICK HERE
16829	National Cancer Institute	Html	en	Cancer Driver Discovery Program	null	large number 0.638311 tumor biology 0.66038 rare driver events 0.719635 comprehensive genomic characterization 0.740363 genomic analyses 0.633135 patient responses 0.721865 tumor tissues 0.638276 additional driver mutations 0.771411 lung cancer 0.952268 statistical models 0.628862 statistical power 0.629897 cancer genomics 0.65394 recurrent mutations 0.655852 patients 0.702611 Genomic Data Commons 0.762952 clinical trial N0147 0.722969 Lung Cancer project 0.792668 molecular causes 0.642033 oncogenic process 0.640394 public health impact 0.739202 epidermal growth factor 0.708102 tumor types 0.658904 Cancer Driver Discovery 0.8155 DNA sequencing 0.651327 Cancer Research UK 0.776689	RNA sequence 0.636519 associated follow-up information 0.721592 ovarian cancers 0.639935 better treatment options 0.776737 clinical outcomes 0.638824 Foundation Lung Cancer 0.793933 intratumoral heterogeneity 0.742723 deeper characterization 0.652385 TRACERx collaborators 0.637079 NCI-funded clinical trial 0.73112 Genome Characterization Pipeline 0.748856 driver mutations 0.919706 St. James 0.824605 Tracking Cancer Evolution 0.775958 CCG 0.851349 colon cancer 0.744767 lung adenocarcinoma 0.669686 TRACERx study 0.634122 total RNA sequencing 0.961331 Cancer Genome Atlas 0.832019 chemotherapy regimen 0.639583 particular lung cancer 0.807795 Central Cancer Treatment 0.762707 genome sequencing 0.685209	CLICK HERE